![Wei Fu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wei Fu
Vorsitzender bei
NOVABRIDGE BIOSCIENCES
Vermögen: 89 Mio $ am 31.05.2026
Profil
Herr Wei Fu ist ein unabhängiger Direktor bei I-Mab, ein Vorsitzender bei Everest Medicines Ltd., ein Chief Executive Officer bei Shanghai Kangshiqiao Business Consulting Co. Ltd., ein Chief Executive Officer & Managing Partner bei C-Bridge Capital Investment Management Ltd. und ein Chief Executive Officer bei Cbc Group Co. Ltd. Er ist Mitglied des Board of Directors bei I-Mab, Ascletis Biopharmaceutical (Hangzhou) Co. Ltd, Everest Medicines (Singapore) Pte Ltd, Everest Medicines II BVI Ltd, Everest Medicines II HK Ltd, Everest Medicines II Ltd, Everonc Medicines Ltd. und Everonc Medicines, Inc. Herr Fu war zuvor als General Manager-Investment Department bei Far East Horizon Ltd. beschäftigt, als Head-Beijing Officer bei Themes Investment Management Ltd., als Associate Director-Private Equity Department bei Standard Chartered Business Consulting Beijing Co. Ltd. und ein Non-Executive Director bei Ascletis Pharma, Inc. Er erhielt seinen Bachelor-Abschluss von der Nanyang Technological University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EVEREST MEDICINES LTD. 6,13 % | 16.06.2026 | 21.683.167 ( 6,13 % ) | 83 Mio $ | 31.05.2026 |
NOVABRIDGE BIOSCIENCES 3,76 % | 29.06.2026 | 7.129.885 ( 3,76 % ) | 6 Mio $ | 30.06.2026 |
Aktuelle Nachrichten zu Wei Fu
Aktive Positionen von Wei Fu
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Vorsitzender | 15.07.2024 |
| EVEREST MEDICINES LIMITED | Direktor/Vorstandsmitglied | 09.10.2025 |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Vorstandsvorsitzender | 01.01.2014 |
Everest Medicines (Singapore) Pte Ltd. | Direktor/Vorstandsmitglied | - |
C-Bridge Capital GP IV Ltd.
 C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Provides investment services | Direktor/Vorstandsmitglied | - |
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Vorsitzender | - |
Affamed Therapeutics (Us), Inc.
 Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Everest Medicines II BVI Ltd. | Direktor/Vorstandsmitglied | - |
Everest Medicines II HK Ltd. | Direktor/Vorstandsmitglied | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Wei Fu
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Wei Fu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
21
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 21 |
|---|---|
Nanyang Technological University
 Nanyang Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Themes Investment Management Ltd.
 Themes Investment Management Ltd. Investment ManagersFinance Themes Investment Management invests in companies located in China. It provides financing for buyout and special situation transactions. It also makes co-investment. | Finance |
Far East Horizon Ltd.
 Far East Horizon Ltd. Finance/Rental/LeasingFinance Provides financial and advisory & industrial operation services | Finance |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Manufactures therapeutic products | Health Technology |
Hugel, Inc.
 Hugel, Inc. BiotechnologyHealth Technology Manufactures and supplies toxin products, cosmetics, medical devices and pharmaceuticals | Health Technology |
CBC Group (Singapore) Pte. Ltd.
CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Finance |
Everest Medicines Ltd.
 Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
Ascletis Pharma, Inc.
 Ascletis Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology firm which develops drugs for HIV, HCV and HBV diseases | Health Technology |
CBC Group Co., Ltd. | |
AffaMed Therapeutics
AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Health Technology |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
C-Bridge Capital Investment Management Ltd. | |
Standard Chartered Business Consulting Beijing Co. Ltd. | |
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Everest Medicines II HK Ltd. | |
Everest Medicines (Singapore) Pte Ltd. | |
Everonc Medicines Ltd. | |
Everonc Medicines, Inc. | |
Everest Medicines II BVI Ltd. | |
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
C-Bridge Capital GP IV Ltd.
C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Wählen Sie MarketScreener 
